ResearcherUniversität UlmNo recent work listed
Martin Müller
Known by name at one institution; no external author ID yet. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 23
2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 2 papers · 2021: 2 papers
Papers 5
- Synergistic targeting and resistance to PARP inhibition in DNA damage repair-deficient pancreatic cancer. Co-author DOI 10.1136/gutjnl-2019-319970↗
- A Prospective Feasibility Trial to Challenge Patient-Derived Pancreatic Cancer Organoids in Predicting Treatment Response. Co-author DOI 10.3390/cancers13112539↗
- Pancreatic cancer-derived organoids - a disease modeling tool to predict drug response. Co-author DOI 10.1177/2050640620905183↗
- Maintenance Therapy for ATM-Deficient Pancreatic Cancer by Multiple DNA Damage Response Interferences after Platinum-Based Chemotherapy. Co-author DOI 10.3390/cells9092110↗
- Tbx3 fosters pancreatic cancer growth by increased angiogenesis and activin/nodal-dependent induction of stemness. Last author DOI 10.1016/j.scr.2016.08.007↗
Closest collaborators
The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Alexander Kleger · 5 shared papers, 2016–2021 · strength 0.43
- Paper A Prospective Feasibility Trial to Challenge Patient-Derived Pancreatic Cancer Organoids in Predicting Treatment Respon… DOI 10.3390/cancers13112539↗
- Paper Maintenance Therapy for ATM-Deficient Pancreatic Cancer by Multiple DNA Damage Response Interferences after Platinum-Ba… DOI 10.3390/cells9092110↗
- Paper Synergistic targeting and resistance to PARP inhibition in DNA damage repair-deficient pancreatic cancer. DOI 10.1136/gutjnl-2019-319970↗
- Thomas Theodor Werner Seufferlein · 5 shared papers, 2016–2021 · strength 0.43
- Paper A Prospective Feasibility Trial to Challenge Patient-Derived Pancreatic Cancer Organoids in Predicting Treatment Respon… DOI 10.3390/cancers13112539↗
- Paper Maintenance Therapy for ATM-Deficient Pancreatic Cancer by Multiple DNA Damage Response Interferences after Platinum-Ba… DOI 10.3390/cells9092110↗
- Paper Synergistic targeting and resistance to PARP inhibition in DNA damage repair-deficient pancreatic cancer. DOI 10.1136/gutjnl-2019-319970↗
- Lukas Perkhofer · 5 shared papers, 2016–2021 · strength 0.43
- Paper A Prospective Feasibility Trial to Challenge Patient-Derived Pancreatic Cancer Organoids in Predicting Treatment Respon… DOI 10.3390/cancers13112539↗
- Paper Maintenance Therapy for ATM-Deficient Pancreatic Cancer by Multiple DNA Damage Response Interferences after Platinum-Ba… DOI 10.3390/cells9092110↗
- Paper Synergistic targeting and resistance to PARP inhibition in DNA damage repair-deficient pancreatic cancer. DOI 10.1136/gutjnl-2019-319970↗
- Johann Gout · 4 shared papers, 2020–2021 · strength 0.38
- Paper A Prospective Feasibility Trial to Challenge Patient-Derived Pancreatic Cancer Organoids in Predicting Treatment Respon… DOI 10.3390/cancers13112539↗
- Paper Maintenance Therapy for ATM-Deficient Pancreatic Cancer by Multiple DNA Damage Response Interferences after Platinum-Ba… DOI 10.3390/cells9092110↗
- Paper Synergistic targeting and resistance to PARP inhibition in DNA damage repair-deficient pancreatic cancer. DOI 10.1136/gutjnl-2019-319970↗
- Élodie Roger · 3 shared papers, 2020–2021 · strength 0.30
- Paper A Prospective Feasibility Trial to Challenge Patient-Derived Pancreatic Cancer Organoids in Predicting Treatment Respon… DOI 10.3390/cancers13112539↗
- Paper Maintenance Therapy for ATM-Deficient Pancreatic Cancer by Multiple DNA Damage Response Interferences after Platinum-Ba… DOI 10.3390/cells9092110↗
- Paper Synergistic targeting and resistance to PARP inhibition in DNA damage repair-deficient pancreatic cancer. DOI 10.1136/gutjnl-2019-319970↗
- Alica K. Beutel · 3 shared papers, 2020–2021 · strength 0.30
- Paper A Prospective Feasibility Trial to Challenge Patient-Derived Pancreatic Cancer Organoids in Predicting Treatment Respon… DOI 10.3390/cancers13112539↗
- Paper Maintenance Therapy for ATM-Deficient Pancreatic Cancer by Multiple DNA Damage Response Interferences after Platinum-Ba… DOI 10.3390/cells9092110↗
- Paper Pancreatic cancer-derived organoids - a disease modeling tool to predict drug response. DOI 10.1177/2050640620905183↗
- Frank Arnold · 3 shared papers, 2020–2021 · strength 0.28
- Paper Maintenance Therapy for ATM-Deficient Pancreatic Cancer by Multiple DNA Damage Response Interferences after Platinum-Ba… DOI 10.3390/cells9092110↗
- Paper Synergistic targeting and resistance to PARP inhibition in DNA damage repair-deficient pancreatic cancer. DOI 10.1136/gutjnl-2019-319970↗
- Paper Pancreatic cancer-derived organoids - a disease modeling tool to predict drug response. DOI 10.1177/2050640620905183↗
- Karolin Walter · 3 shared papers, 2016–2021 · strength 0.22
- Paper Synergistic targeting and resistance to PARP inhibition in DNA damage repair-deficient pancreatic cancer. DOI 10.1136/gutjnl-2019-319970↗
- Paper Pancreatic cancer-derived organoids - a disease modeling tool to predict drug response. DOI 10.1177/2050640620905183↗
- Paper Tbx3 fosters pancreatic cancer growth by increased angiogenesis and activin/nodal-dependent induction of stemness. DOI 10.1016/j.scr.2016.08.007↗
- Patrick Christian Hermann · 3 shared papers, 2016–2021 · strength 0.22
- Paper Synergistic targeting and resistance to PARP inhibition in DNA damage repair-deficient pancreatic cancer. DOI 10.1136/gutjnl-2019-319970↗
- Paper Pancreatic cancer-derived organoids - a disease modeling tool to predict drug response. DOI 10.1177/2050640620905183↗
- Paper Tbx3 fosters pancreatic cancer growth by increased angiogenesis and activin/nodal-dependent induction of stemness. DOI 10.1016/j.scr.2016.08.007↗
- Hans Armin Kestler · 2 shared papers, 2021 · strength 0.20
- Thomas Jens Ettrich · 2 shared papers, 2020–2021 · strength 0.19
- Pierre‐Olivier Frappart · 2 shared papers, 2020–2021 · strength 0.17
- Bruno Sáinz · 2 shared papers, 2020–2021 · strength 0.17
- Marko Kornmann · 1 shared paper, 2021 · strength 0.11
- Johannes Lemke · 1 shared paper, 2021 · strength 0.11
- Eva Rodríguez-Aznar · 1 shared paper, 2021 · strength 0.09
- Sebastian Lange · 1 shared paper, 2021 · strength 0.09
- Stephan A. Hahn · 1 shared paper, 2021 · strength 0.09
- Roland Rad · 1 shared paper, 2021 · strength 0.09
- Diane M. Simeone · 1 shared paper, 2021 · strength 0.09
- Elisabeth Heßmann · 1 shared paper, 2021 · strength 0.09
- Thilo Hackert · 1 shared paper, 2020 · strength 0.08
- Tim Eiseler · 1 shared paper, 2016 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.